Chinese Teen Invents Wearable Forget-Me-Not for Grandma
Alzheimer’s disease is a common form of dementia among older people worldwide. In China, there are about 10 million Alzheimer’s patients, ranking first in the world. By 2050, the number of Alzheimer’s...
View ArticleFDA Unanimously Votes Leqembi Benefits Alzheimer’s
The FDA Peripheral and Central Nervous System Drugs Advisory Committee unanimously voted that lecanemab (leqembi) showed clinical benefit in early Alzheimer’s disease, paving the way for a traditional...
View ArticleNew Alzheimer’s Drug Lecanemab: High price tag, Moderate warnings
The Food and Drug Administration (FDA) has granted traditional approval for generic lecanemab (brand name Leqembi®). The new treatment promises to slow the decline of memory and thinking in some...
View ArticleLilly’s Donanemab: The 3rd New Alzheimer’s Drug
Highlights Donanemab significantly slowed cognitive and functional decline for amyloid-positive early symptomatic Alzheimer’s disease patients, lowering their risk of disease progression; nearly half...
View ArticlePrescribing Lecanemab in Real Life
On July 6, 2023, the U.S. Food and Drug Administration (FDA) granted full approval for the Alzheimer’s disease drug Leqembi (lecanemab-irmb), the first medicine shown to delay the course of the...
View ArticleTau-PET Best Predictor of Alzheimer’s Cognitive Decline
Alzheimer’s disease, one of the most common neurodegenerative diseases, leads to progressive loss of memory and autonomy. It is characterised by the accumulation of neurotoxic proteins in the brain,...
View ArticleFerroptosis Builds Up Brain Iron, Triggering Alzheimer’s
Scientists at Oregon’s only public academic health center (OHSU) have discovered a new avenue of cell death in Alzheimer’s disease and vascular dementia. A new study, led by scientists at Oregon...
View ArticleThe Genetic Factor That Fends Off Alzheimer’s
About one in every five people carries a version of a gene that, although largely unsung, appears to confer protection against both Alzheimer’s disease and Parkinson’s disease, Stanford Medicine...
View ArticleClik here to view.
PrecivityAD™ Blood Test Helps Diagnose Alzheimer’s
A peer-reviewed journal has published the first research paper to state that the PrecivityAD blood test “can accurately identify brain amyloid status based on a single blood sample.” The research...
View ArticleClik here to view.
3D-Printed Brain Tissue Accelerates Alzheimer’s Research
A team of University of Wisconsin–Madison scientists has developed the first 3D-printed brain tissue that can grow and function like typical brain tissue. It’s an achievement with important...
View Article